Predicting T‐cell quality during manufacturing through an artificial intelligence‐based integrative multiomics analytical platform

Large‐scale, reproducible manufacturing of therapeutic cells with consistently high quality is vital for translation to clinically effective and widely accessible cell therapies. However, the biological and logistical complexity of manufacturing a living product, including challenges associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Odeh‐Couvertier, Valerie Y., Dwarshuis, Nathan J., Colonna, Maxwell B., Levine, Bruce L., Edison, Arthur S., Kotanchek, Theresa, Roy, Krishnendu, Torres‐Garcia, Wandaliz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115702/
https://www.ncbi.nlm.nih.gov/pubmed/35600660
http://dx.doi.org/10.1002/btm2.10282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115702/
https://www.ncbi.nlm.nih.gov/pubmed/35600660
http://dx.doi.org/10.1002/btm2.10282

Ejemplares similares